Companies you'll love to work for

Locations

Boston, MA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series B

founded in

2019

Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.

Something looks off?
Open jobs at Ensoma

On-site & Remote